Initiating Clinical Trials: A Case Study of Intermittent Positive Pressure Breathing
$20.00
{{option.name}}:
{{selected_options[option.position]}}
{{value_obj.value}}
Describes the events surrounding the decision by the National Heart and Lung Institute (NHLI) to issue a request for proposal (RFP) to conduct a multicenter randomized clinical trial comparing the efficacy of intermittent positive pressure breathing (IPPB) with compressor nebulizer therapy in treating patients with chronic obstructive pulmonary disease (COPD).
Show More
Show Less